Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lipotoxin for Interstitial Cystitis
NCT02247557Phase 2Completed
- Sponsor
- Buddhist Tzu Chi General Hospital
- Start
- Sep 2014
- Primary completion
- Feb 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of botulinum toxin type A in interstitial cystitis (IC) (3 arms), sponsored by Buddhist Tzu Chi General Hospital. Primary endpoint: O'Leary-Sant Symptom Score at 1 month. Started Sep 2014; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
interstitial cystitis (IC)
Beyond the preview
Go deeper on NCT02247557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02247557.